AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2022
Aug 23, 2022
35599_dirs_2022-08-23_797d56f3-dcd1-4bdb-ad4f-2fadde71b0e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2022-08-22
Reporting Person: Raykov Rosty (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-22 | Common Shares | $1.05 | M | 50000 | Acquired | 2022-11-20 | options (50000) | Direct |
Footnotes
F1: Represents options granted on November 20, 2012, with a $1.05 USD strike price and an expiration of November 20, 2022.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20